CTRI registered clinical trial (reference: CTRI/2014/01/004277)
Conducted in 42 psoriasis patients for 12 weeks
Study findings
Toxicity Studies
Complete toxicity studies were conducted on Psorolin Ointment under OECD (Organization for Economic Co-operation and Development) guidelines for Toxicity studies.
NAME OF THE STUDY | REFERENCE OECD NO | FINDINGS FOR Dr.JRK’S 777 OIL |
---|---|---|
![]() Skin Sensitization in Guinea pig |
406 | Did not produce skin sensitization effect after 24 h and 48 h of removal of the patch |
![]() Effect on Mucus membrane |
405 | Did not produce mucus membrane irritation |
![]() In vitro Mammalian cell gene mutation test- chinese hamster ovary K1 cell line |
476 | Did not show any mutagenic effect |
![]() Bacterial reverse mutation test using S. typhimurium and E.coli WP2 uvr A |
471 | Did not show any mutagenic effect on all four strains of S. typhimurium and E.coli |
![]() Mammalian erythrocyte Micronucleus testing swiss albino mice |
474 | Did not produce toxic effect on bone marrow and total polychromatic/ erythrocyte ratio (P/E). |
![]() Acute lethal dose |
408 | No change in the viscera/ organs and in the histological parameters was observed even in the animals that received high dose of the product. |
![]() Reproduction developmental toxicity screening |
421 | Did not produce reproduction and developmental toxicity.Pups – did not reveal any abnormalities either at reproductive and histological level |
Effect of Topical application of Psorolin ointment in management of Pityriasis versicolor
Study findings
Psorolin ointment effective in inhibition of human keratinocytes multiplication.
Psorolin ointment at various concentrations (0.2-100mg/ml) was evaluated by MTT assay using HaCaT cell line to determine its efficacy in inhibiting keratinocytes proliferation.
Study findings